Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2019

Feb 27, 2019

29831_dirs_2019-02-26_9c903153-7a9b-4bc6-8536-3d7df71504c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-02-23

Reporting Person: Dolsten Mikael (President R&D)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-23 Common Stock F 54568.0000 $42.9600 Disposed 310078.0000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1625.0000 Indirect

Footnotes

F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).

F2: Price is the closing price of Pfizer common stock on February 22, 2019